Cargando…
Current status of iridium-based complexes against lung cancer
Lung cancer is one of the most common malignant tumors, with the highest mortality rate in the world, and its incidence is second only to breast cancer. It has posed a serious threat to human health. Cisplatin, a metal-based drug, is one of the most widely used chemotherapeutic agents for the treatm...
Autores principales: | Yang, Tongfu, Zhu, Minghui, Jiang, Ming, Yang, Feng, Zhang, Zhenlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538862/ https://www.ncbi.nlm.nih.gov/pubmed/36210835 http://dx.doi.org/10.3389/fphar.2022.1025544 |
Ejemplares similares
-
Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022) -
Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
por: Zulfiqar, Bilal, et al.
Publicado: (2022) -
Radical scavenging capacity, antibacterial activity, and quantum chemical aspects of the spectrophotometrically investigated iridium (III) complex with benzopyran derivative
por: Mohmad, Masrat, et al.
Publicado: (2022) -
Corrigendum: Radical scavenging capacity, antibacterial activity, and quantum chemical aspects of the spectrophotometrically investigated iridium (III) complex with benzopyran derivative
por: Mohmad, Masrat, et al.
Publicado: (2022) -
Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
por: Liu, Wenliang, et al.
Publicado: (2022)